DNA tests: Who is getting rich with the data from our genes? | DW Documentary

Key Concepts

• Personal Genetic Testing: Direct-to-consumer DNA tests for ancestry and health insights.
• DNA (Deoxyribonucleic Acid): A macromolecule containing encrypted genetic information passed down through generations.
• Database Building: Companies collecting DNA data to expand their databases for various purposes.
• Data Monetization: Companies generating revenue by selling access to their databases to pharmaceutical companies and other entities.
• Genetic Discrimination: Discrimination based on an individual's genetic predispositions, particularly in insurance.
• Data Security Breaches: Unauthorized access and theft of user data, including genetic information, from DNA testing companies.
• Terms of Service: Legal agreements that users must accept, which dictate how their data can be used and shared.
• Biometric Variable: DNA as a biological identifier that can be used to categorize and discriminate against individuals.

Main Topics and Key Points

1. The Rise of Personal Genetic Testing

• Market Growth: The at-home testing market is worth over $2 billion and is expected to grow significantly.
• Key Players: Ancestry (linked to the Mormons), 23andMe, and MyHeritage are major companies in the industry.
• Marketing Strategies: Companies use advertisements, celebrity endorsements, and genealogy-themed reality shows to attract customers.
• Testing Process: Customers provide saliva samples, which are compared to proprietary databases to estimate ancestry and health risks.

2. Accuracy and Scientific Validity

• Calculation Complexity: Determining ancestry involves complex calculations and theories that companies may not fully verify.
• Lack of Transparency: Companies often keep their calculation methods secret, hindering scientific evaluation.
• Misuse of Terms: Companies may simplify results by misusing scientific terms.
• Limited Scope: Inexpensive tests decode only a small portion of the genetic material, raising concerns about reliability.
• Skepticism from Scientists: Researchers are skeptical due to the lack of transparency and scientific rigor.

3. Business Models and Data Monetization

• Database as Revenue Generator: Companies view the database of genetic information as their primary revenue source.
• Healthcare Market: Companies are expanding into the healthcare market by offering insights into disease risks.
• Partnerships with Pharmaceutical Companies: Companies sell access to their databases to pharmaceutical companies for drug development.
• Data Value Decline: The estimated value of an individual's genetic data has decreased over time.
• Limited Scientific Discoveries: Internal research at companies like 23andMe has not yielded significant breakthroughs.

4. Ethical Concerns and Risks

• Data Privacy: Entrusting genetic data to companies raises concerns about privacy and potential misuse.
• Genetic Discrimination: Insurance companies may use genetic information to discriminate against individuals, particularly in countries like New Zealand.
• Data Security Breaches: Companies are vulnerable to cyberattacks, leading to the theft and sale of user data.
• Changing Terms of Service: Companies may alter their terms of service to monetize data in ways that users did not initially agree to.
• Impact on Family Members: Providing genetic information affects not only the individual but also their family members.

5. Case Studies and Examples

• Iceland and Decode Genetics: Carrie Stefansson's attempt to collect the genetic material of the entire Icelandic population faced ethical challenges and legal obstacles.
• 23andMe and Ann Wojcicki: The company's success was driven by marketing expertise and support from Google co-founder Sergey Brin.
• Anique Greenhill in New Zealand: A woman with a BRCA1 mutation faced discrimination from insurance companies and had to undergo preventative surgeries.
• 23andMe Data Breach: Hackers stole the data of millions of users, raising concerns about data security and potential misuse.

6. Genetic Discrimination in New Zealand

• Policy Requirement: Insurance companies in New Zealand require customers to disclose any genetic tests they have taken.
• Discrimination Against BRCA1 Carriers: Anique Greenhill was denied insurance coverage due to her BRCA1 mutation.
• Impact on Health Practices: Concerns about insurance implications may deter people from getting genetic tests.
• Andrew Shelling's Fight: Professor Andrew Shelling is leading the fight against genetic discrimination in New Zealand.

7. Data Security Breach at 23andMe

• Hacker's Post: A hacker offered to sell millions of DNA records on a hacker forum.
• Data Offered for Sale: The hacker offered data on multiple ethnic groups, including appearance, photos, and account information.
• Impact on Users: The personal data of almost 7 million users was compromised.
• Company Response: 23andMe agreed to pay $30 million in damages.

Step-by-Step Processes, Methodologies, or Frameworks Explained

• DNA Testing Process:
  1. Customer provides a saliva sample.
  2. The company extracts DNA from the sample.
  3. The company compares the DNA to its database.
  4. The company calculates probabilities based on differences in DNA.
  5. The company provides the customer with ancestry and health reports.

Key Arguments or Perspectives Presented, with Their Supporting Evidence

• Personal genetic testing is not always accurate or scientifically valid.
  • Companies may not fully verify complex calculations.
  • Calculation methods are often kept secret.
  • Inexpensive tests decode only a small portion of the genetic material.
• Personal genetic testing companies are primarily interested in building databases for data monetization.
  • The price of test kits has dropped significantly, suggesting they are sold at a loss.
  • Companies partner with pharmaceutical companies to sell access to their databases.
• Personal genetic testing raises ethical concerns about data privacy, genetic discrimination, and data security.
  • Insurance companies may use genetic information to discriminate against individuals.
  • Companies are vulnerable to cyberattacks, leading to the theft and sale of user data.

Notable Quotes or Significant Statements with Proper Attribution

• "The more precise you want to be, the less it works." - Scientist formerly employed by 23andMe (speaking anonymously about defining clear boundaries for a DNA sequence).
• "If you're not paying for the product, you are the product." - A saying in tech circles, highlighting the data collection aspect of mass market DNA testing.
• "We should be worried. We should definitely be worried when private equity moves in. The idealists leave and the the money money men come in is what I would say." - Commenting on Blackstone's acquisition of Ancestry.
• "DNA is a biometric variable. It can be used to categorize people to discriminate." - Emphasizing the potential for misuse of genetic information.

Technical Terms, Concepts, or Specialized Vocabulary with Brief Explanations

• DNA (Deoxyribonucleic Acid): A macromolecule containing encrypted genetic information passed down through generations.
• Genome: The complete set of genetic material in an organism.
• Chromosomes: Structures within cells that contain DNA. Humans have 23 pairs of chromosomes.
• SNPs (Single Nucleotide Polymorphisms): Variations in a single nucleotide (A, T, C, or G) within a DNA sequence.
• Algorithm: A set of rules or instructions used to solve a problem or perform a calculation.
• Peer Review: The evaluation of scientific work by other experts in the field.
• Database: A structured set of data held in a computer, especially one that is accessible in various ways.
• Biometric: A biological measurement or characteristic that can be used to identify an individual.

Logical Connections Between Different Sections and Ideas

The video begins by introducing the concept of personal genetic testing and its growing popularity. It then delves into the scientific validity of these tests, questioning their accuracy and transparency. This leads to a discussion of the business models of DNA testing companies, highlighting their reliance on data collection and monetization. The video then explores the ethical concerns and risks associated with personal genetic testing, including data privacy, genetic discrimination, and data security breaches. Case studies and examples are used to illustrate these points, such as the situation in New Zealand regarding genetic discrimination in insurance and the data breach at 23andMe. The video concludes by emphasizing the potential for misuse of genetic information and the need to protect it from private interests.

Data, Research Findings, or Statistics Mentioned

• The global at-home testing market is worth more than $2 billion.
• Ancestry has 3 million subscribers and a network of over 27 million people.
• 23andMe claims to have 13 million customers worldwide.
• The estimated annual growth rate of the healthcare DNA testing industry is up to 20%.
• In 2018, GlaxoSmithKline put $300 million in equity into 23andMe for access to their database.
• Blackstone paid nearly $5 billion to acquire Ancestry in 2020.
• The personal data of almost 7 million 23andMe users was compromised in a data breach.
• 23andMe agreed to pay $30 million in damages for the data breach.

Brief Synthesis/Conclusion of the Main Takeaways

Personal genetic testing has become increasingly popular, but it raises significant concerns about accuracy, data privacy, genetic discrimination, and data security. While these tests can provide insights into ancestry and health risks, their scientific validity is questionable, and companies often prioritize data collection and monetization over scientific rigor. The potential for misuse of genetic information, particularly in insurance and by cybercriminals, highlights the need for greater regulation and protection of this sensitive data.